Volcano Corporation

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Volcano Corporation sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).

10 total trials none currently recruiting 8 completed top decile by trial count

Volcano Corporation: 10 sponsored US clinical trials, none currently recruiting.

Volcano Corporation sponsors 10 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 8 completed. The most-studied condition in this pipeline is Coronary Artery Disease, with 1 trials.

Top-decile sponsor footprint

Volcano Corporation ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 39/100

8 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

10 total, page 1 of 1

COMPLETED

Radiographic Imaging Validation and EvALuation for Angio iFR (ReVEAL iFR)

NCT03857503
COMPLETED

Physiologic Assessment of Coronary Stenosis Following PCI

NCT03084367
TERMINATED

Short-term Perfusion Angiography Pilot Study (SPA)

NCT03054636
COMPLETED

Phoenix Post-Approval Registry - Using the Phoenix Atherectomy Systems

NCT02475200
TERMINATED NA

Evaluation of the Technical Success of IVUS Guided VCF Placement Using the LUMIFI™ With Crux® VCF System

NCT02394912
COMPLETED

Venogram vs. Intravascular Ultrasound (IVUS) for Diagnosing Iliac Vein Obstruction

NCT02142062
COMPLETED

Pilot Study of IVUS Imaging During Endovascular Interventions of Failing Hemodialysis Access Grafts

NCT01929369
COMPLETED

ADenosine Vasodilator Independent Stenosis Evaluation II - ADVISE II

NCT01740895
COMPLETED

Fractional Flow Reserve and Intravascular Ultrasound RelationShip STudy

NCT01153555
COMPLETED

Bifurcation Lesion Analysis and STenting / BLAST

NCT02316782

Therapeutic Areas

Coronary Artery Disease 1

How the Volcano Corporation archive is shaped

10 indexed studies, none listed as recruiting (0% open); 8 completed (80%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Coronary Artery Disease (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Volcano Corporation: archived-pipeline peers nationwide

Peers matched on 10 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Volcano Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share Volcano CorporationAdamas PharmaceuticalsAdverum BiotechnologiesAevi Genomic Medicine, LLC, a Cerecor companyAgouron Pharmaceuticals10xBio22nd Century Group23andMe3-C Institute for Social Development
Volcano Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Volcano Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 10 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Volcano Corporation page

10 registered trials is a research-attention snapshot, not an endorsement of Volcano Corporation or any single study.

  • None of Volcano Corporation's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Coronary Artery Disease is the condition Volcano Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Volcano Corporation pipeline card: 10 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.